Monday, September 21, 2015 10:21:46 PM
Lisa Stepp, Senior Director Medical Affairs for PPHM is listed as Faculty of the upcoming Medical Affairs Strategic Summit in San Diego 9/30-10/2.
ECG, after a couple days of this to sink in and after seeing Lisa and her association with only Peregrine in this upcoming Summit in San Diego "only" showing Peregrine and not Gilead has me curious and I'd say she will do better than Vladimir Evilevitch
------------
STRATEGIES FOR MSL OPERATIONAL IMPROVEMENT AND TEAM
RETENTION
• Hear best practices to manage a team of MSLs and effectively
communicate goals, compliance expectations and limitations
• Explore different corporate initiatives to motivate and achieve higher retention of MSLs
• Learn about the most common mistakes made when managing field
teams and how to improve communication with MSLs
Lisa Stepp, Senior Director Medical Affairs,
PEREGRINE PHARMACEUTICALS, INC.
http://info.exlevents.com/rs/195-NER-971/images/C593-MassWestBrochure.pdf
-------------------------------
Sr. Director Medical Affairs
Peregrine Pharmaceuticals, Inc.
March 2015 – Present (7 months)Tustin, CA
Director Clinical Research-Oncology and Inflammation Therapeutics
Gilead Sciences
July 2012 – Present (3 years 3 months)Foster City, CA
https://www.linkedin.com/pub/lisa-stepp-phd-mba/a/942/345
-----------------------------
"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!
